Suppr超能文献

早发性帕金森病中LRRK2 G2019S携带者的运动表型

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease.

作者信息

Alcalay Roy N, Mejia-Santana Helen, Tang Ming Xin, Rosado Llency, Verbitsky Miguel, Kisselev Sergey, Ross Barbara M, Louis Elan D, Comella Cynthia L, Colcher Amy, Jennings Danna, Nance Martha A, Bressman Susan, Scott William K, Tanner Caroline, Mickel Susan F, Andrews Howard F, Waters Cheryl H, Fahn Stanley, Cote Lucien J, Frucht Steven J, Ford Blair, Rezak Michael, Novak Kevin, Friedman Joseph H, Pfeiffer Ronald, Marsh Laura, Hiner Bradley, Siderowf Andrew, Caccappolo Elise, Ottman Ruth, Clark Lorraine N, Marder Karen S

机构信息

Department of Neurology, Columbia University, New York, NY 10032, USA.

出版信息

Arch Neurol. 2009 Dec;66(12):1517-22. doi: 10.1001/archneurol.2009.267.

Abstract

OBJECTIVE

To determine the motor phenotype of LRRK2 G2019S mutation carriers. LRRK2 mutation carriers were previously reported to manifest the tremor dominant motor phenotype, which has been associated with slower motor progression and less cognitive impairment compared with the postural instability and gait difficulty (PIGD) phenotype.

DESIGN

Cross-sectional observational study.

SETTING

Thirteen movement disorders centers.

PARTICIPANTS

Nine hundred twenty-five early-onset Parkinson disease cases defined as age at onset younger than 51 years.

MAIN OUTCOME MEASURES

LRRK2 mutation status and Parkinson disease motor phenotype: tremor dominant or PIGD. Demographic information, family history of Parkinson disease, and the Unified Parkinson's Disease Rating Scale score were collected on all participants. DNA samples were genotyped for LRRK2 mutations (G2019S, I2020T, R1441C, and Y1699C). Logistic regression was used to examine associations of G2019S mutation status with motor phenotype adjusting for disease duration, Ashkenazi Jewish ancestry, levodopa dose, and family history of Parkinson disease.

RESULTS

Thirty-four cases (3.7%) (14 previously reported) were G2019S carriers. No other mutations were found. Carriers were more likely to be Ashkenazi Jewish (55.9% vs 11.9%; P < .001) but did not significantly differ in any other demographic or disease characteristics. Carriers had a lower tremor score (P = .03) and were more likely to have a PIGD phenotype (92.3% vs 58.9%; P = .003). The association of the G2019S mutation with PIGD phenotype remained after controlling for disease duration and Ashkenazi Jewish ancestry (odds ratio, 17.7; P < .001).

CONCLUSION

Early-onset Parkinson disease G2019S LRRK2 carriers are more likely to manifest the PIGD phenotype, which may have implications for disease course.

摘要

目的

确定LRRK2基因G2019S突变携带者的运动表型。先前有报道称,LRRK2突变携带者表现为震颤为主的运动表型,与姿势不稳和步态障碍(PIGD)表型相比,其运动进展较慢且认知障碍较少。

设计

横断面观察性研究。

地点

13个运动障碍中心。

参与者

925例早发性帕金森病病例,定义为发病年龄小于51岁。

主要观察指标

LRRK2突变状态和帕金森病运动表型:震颤为主型或PIGD型。收集所有参与者的人口统计学信息、帕金森病家族史以及统一帕金森病评定量表评分。对DNA样本进行LRRK2突变(G2019S、I2020T、R1441C和Y1699C)基因分型。采用逻辑回归分析,在调整病程、阿什肯纳兹犹太血统、左旋多巴剂量和帕金森病家族史后,研究G2019S突变状态与运动表型之间的关联。

结果

34例(3.7%)(其中14例先前已报道)为G2019S携带者。未发现其他突变。携带者更有可能是阿什肯纳兹犹太人(55.9%对11.9%;P < 0.001),但在其他任何人口统计学或疾病特征方面无显著差异。携带者的震颤评分较低(P = 0.03),且更有可能具有PIGD表型(92.3%对58.9%;P = 0.003)。在控制病程和阿什肯纳兹犹太血统后,G2019S突变与PIGD表型之间的关联仍然存在(优势比为17.7;P < 0.001)。

结论

早发性帕金森病LRRK2基因G2019S突变携带者更有可能表现出PIGD表型,这可能对疾病进程有影响。

相似文献

1
Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease.
Arch Neurol. 2009 Dec;66(12):1517-22. doi: 10.1001/archneurol.2009.267.
2
Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.
Mov Disord. 2013 Dec;28(14):1966-71. doi: 10.1002/mds.25647. Epub 2013 Oct 15.
3
Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease.
Parkinsonism Relat Disord. 2015 Feb;21(2):106-10. doi: 10.1016/j.parkreldis.2014.09.033. Epub 2014 Nov 20.
4
Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.
Mov Disord. 2015 Feb;30(2):253-8. doi: 10.1002/mds.26097. Epub 2014 Dec 9.
5
The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: clinical and demographic characteristics.
Neurosci Lett. 2013 Mar 14;537:1-5. doi: 10.1016/j.neulet.2013.01.011. Epub 2013 Jan 20.
6
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
Neurology. 2006 Nov 28;67(10):1786-91. doi: 10.1212/01.wnl.0000244345.49809.36. Epub 2006 Oct 18.
7
Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controls.
J Neurol Sci. 2018 May 15;388:203-207. doi: 10.1016/j.jns.2018.03.025. Epub 2018 Mar 17.
8
Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation.
Mov Disord. 2013 Oct;28(12):1683-90. doi: 10.1002/mds.25587. Epub 2013 Oct 7.
9
The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
Neurology. 2007 Oct 16;69(16):1595-602. doi: 10.1212/01.wnl.0000277637.33328.d8.

引用本文的文献

1
The Impact of LRRK2 G2019S on Parkinson's Disease: Clinical Phenotype and Treatment in Tunisian Patients.
J Mov Disord. 2024 Jul;17(3):294-303. doi: 10.14802/jmd.23276. Epub 2024 Apr 23.
3
Clinical and genetic analysis of Vietnamese patients diagnosed with early-onset Parkinson's disease.
Brain Behav. 2023 Apr;13(4):e2950. doi: 10.1002/brb3.2950. Epub 2023 Mar 6.
4
Generalized dystonia without Parkinsonism in an carrier.
Clin Park Relat Disord. 2022 Jul 21;7:100157. doi: 10.1016/j.prdoa.2022.100157. eCollection 2022.
5
Freezing of gait: overview on etiology, treatment, and future directions.
Neurol Sci. 2022 Mar;43(3):1627-1639. doi: 10.1007/s10072-021-05796-w. Epub 2022 Jan 14.
6
Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease.
J Neurosurg. 2021 Nov 19;137(1):184-191. doi: 10.3171/2021.7.JNS21190. Print 2022 Jul 1.
7
Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor Subtypes.
Neurol Genet. 2021 Jan 28;7(2):e557. doi: 10.1212/NXG.0000000000000557. eCollection 2021 Apr.
8
Role of variant p.Gly2019Ser in patients with Parkinsonism.
Indian J Med Res. 2020 Jun;151(6):592-597. doi: 10.4103/ijmr.IJMR_25_18.
9
Postural Instability in Parkinson's Disease: A Review.
Brain Sci. 2019 Sep 18;9(9):239. doi: 10.3390/brainsci9090239.
10
Clinical Heterogeneity Among Variants in Parkinson's Disease: A Meta-Analysis.
Front Aging Neurosci. 2018 Sep 19;10:283. doi: 10.3389/fnagi.2018.00283. eCollection 2018.

本文引用的文献

2
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
Lancet Neurol. 2008 Jul;7(7):583-90. doi: 10.1016/S1474-4422(08)70117-0. Epub 2008 Jun 6.
3
Tremor dominant parkinsonism: Clinical description and LRRK2 mutation screening.
Mov Disord. 2008 Mar 15;23(4):518-23. doi: 10.1002/mds.21771.
4
Prognostic factors for the progression of Parkinson's disease: a systematic review.
Mov Disord. 2007 Oct 15;22(13):1839-51; quiz 1988. doi: 10.1002/mds.21537.
5
Clinical diagnostic criteria for dementia associated with Parkinson's disease.
Mov Disord. 2007 Sep 15;22(12):1689-707; quiz 1837. doi: 10.1002/mds.21507.
6
Cognitive impairment in Parkinson's disease.
J Neurol Neurosurg Psychiatry. 2007 Nov;78(11):1182-7. doi: 10.1136/jnnp.2006.112367. Epub 2007 Apr 18.
8
G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies.
J Neurol Neurosurg Psychiatry. 2007 Jun;78(6):626-8. doi: 10.1136/jnnp.2006.107904. Epub 2007 Jan 8.
9
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
Neurology. 2006 Nov 28;67(10):1786-91. doi: 10.1212/01.wnl.0000244345.49809.36. Epub 2006 Oct 18.
10
LRRK2 gene and tremor-dominant parkinsonism.
Arch Neurol. 2006 Sep;63(9):1346-7. doi: 10.1001/archneur.63.9.1346-b.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验